Pros

Search documents
Grant Funding Investment at South Crofty Tin Project
Globenewswire· 2025-06-12 06:00
The grant funding is equivalent to a maximum of 62% of the total Bartles Foundry project cost estimated at approximately £6.8 million for the construction of workshops, stores and offices on the Bartles Foundry site. This will support the requirements associated with South Crofty moving to production and includes the cost for the previously announced purchase of 4.5 acres of land from Cornwall Council (see press release dated April 1, 2025). Conditional planning approval for the development was granted in J ...
Legacy Housing Corporation: Patience Should Pay Off
Seeking Alpha· 2025-06-11 11:36
I always find myself drawn to interesting companies. These aren't necessarily the high growth names that people are so obsessed with nowadays. Rather, they are usually smaller firms that operate in niche industries. I find that some of the most attractive prospects fallCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50 ...
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
GlobeNewswire· 2025-06-11 10:30
Core Insights - Teleflex Incorporated has launched two initiatives to raise awareness about benign prostatic hyperplasia (BPH) during Men's Health Month, focusing on quality-of-life issues and potential rectal toxicity from prostate cancer radiation treatment [3][8]. Group 1: Awareness Initiatives - The initiatives include the "Prostate Monster" ad campaign and the Prostate Education Express, a mobile training center that will tour major U.S. cities throughout 2025 [4][5]. - The Prostate Education Express aims to educate both physicians and the community about BPH and the benefits of the UroLift™ System and Barrigel™ rectal spacer [4][7]. Group 2: UroLift™ System - The UroLift™ System is a minimally invasive treatment for BPH symptoms, indicated for men aged 45 and older, and has been used to treat over 500,000 men globally [10][6]. - A clinical study showed a low retreatment rate of about 2-3% per year, indicating the durability of the UroLift™ System [10]. Group 3: Barrigel™ Rectal Spacer - Barrigel™ rectal spacer is the first hyaluronic acid rectal spacer designed to protect the rectum during radiation therapy for prostate cancer, with over 50,000 men treated [12][8]. - A clinical study found that 98.5% of men treated with Barrigel™ achieved at least a 25% reduction in radiation to the rectum, with an average reduction of 85% [8].
Insmed (INSM) Update / Briefing Transcript
2025-06-10 13:00
Insmed (INSM) Update / Briefing June 10, 2025 08:00 AM ET Speaker0 Thank you for standing by, and welcome to the Insmed Phase 2b PAH Top Line Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer Thank you. I'd now like to turn the call over to Brian Dunn, Head of Investor Relations. You may begin. Speaker1 Thank you, Rob. Good day, everyone, and welcome to today's conference call to discuss the top line ...
Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension
Prnewswire· 2025-06-10 11:00
–The Study Met Primary and All Secondary Efficacy Endpoints– –TPIP Was Well Tolerated in the Study, with 75% of Patients Titrating to the Highest Dose– –Insmed to Immediately Engage with FDA to Inform Phase 3 Trial Design with Studies Expected to Begin Before End of 2025 for PH-ILD and in Early 2026 for PAH– –Insmed to Host Investor Call at 8:00 AM ET on Tuesday, June 10, 2025– BRIDGEWATER, N.J., June 10, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical compan ...
Guide to Aerospace & Defense ETFs
ZACKS· 2025-06-05 12:31
Global Defense Spending - Global defense spending reached an all-time high of $2.72 trillion in 2024, marking a 9.4% year-over-year increase, the sharpest rise since the Cold War era [1] - The top five spenders—United States, China, Russia, Germany, and India—accounted for 60% of the global defense budget, with U.S. military expenditure growing by 5.7% to $997 billion, representing 37% of total global defense spending [2] European Union Defense Spending - EU member states are expected to increase annual defense spending by around €80 billion ($84 billion) by 2027, equivalent to roughly 0.5% of GDP [6] - Defense expenditures in the euro area accounted for 1.8% of GDP in 2024, projected to rise to 2.4% by 2027, with Germany's military spending jumping 28% to $88.5 billion [7] Factors Driving Increased Spending - Global defense spending has been rising since Russia's invasion of Ukraine, with Europe significantly increasing military equipment purchases from non-EU suppliers [8] - All 32 NATO members increased defense budgets in 2024, with 18 countries meeting or exceeding the bloc's 2% of GDP target [9] Aerospace and Defense Sector Performance - The aerospace sector saw earnings grow by 23.2% in Q1, with an 85.7% beat ratio, while revenues increased by 0.2% with a 71.4% beat ratio [5] - The Zacks Aerospace-Defense industry ranks in the top 20% of over 250 Zacks industries, indicating strong investor interest in defense and aerospace stocks [10] Exchange-Traded Funds (ETFs) in Aerospace and Defense - Several ETFs focus on the aerospace and defense sector, including iShares U.S. Aerospace & Defense ETF (ITA), Invesco Aerospace & Defense ETF (PPA), and SPDR S&P Aerospace & Defense ETF (XAR), each with varying fee structures [12][13][14] - The Global X Defense Tech ETF (SHLD) provides exposure to defense technology companies, with a significant allocation to the U.S. [15]
Liquidia Corp (LQDA) 2025 Conference Transcript
2025-06-04 16:07
Liquidia Corp (LQDA) 2025 Conference June 04, 2025 11:05 AM ET Speaker0 Welcome to the Jefferies Global Healthcare Conference. My name is Kombe Ziazi. I'm a biotech analyst here at Jefferies. Today, it's my distinct honor and pleasure to welcome Liquidia Therapeutics CEO, Roger Jeffs, and CFO, Mike Caseta. Coming off a recent drug approval for Eutrebia. Welcome gentlemen. Thank you, Combes. Roger, maybe I'll allow you to have some open remarks because Eutrebia was so recently approved. We'd just love to hea ...
PROCEPT BioRobotics (PRCT) FY Conference Transcript
2025-06-04 16:00
PROCEPT BioRobotics (PRCT) FY Conference June 04, 2025 11:00 AM ET Speaker0 Hello? Sorry. Hi, everyone. My name is Brandon Vasquez. I am the analyst here at William Blair that covers Procept biorobotics. I am required to tell you and inform you to go to our website at williamblair.com a complete list of disclosures and conflicts of interests. With that said, happy to have president and CEO Reza Zadno with us. He's gonna run us through a company presentation before we go to our breakout. So with that, I'll t ...
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
Globenewswire· 2025-06-03 20:30
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor (ARi) for the treatment of patients with hormone-sensitive prostate cancer (mHSPC), in combination with androgen deprivation therapy (ADT), with or without chemotherapy.This third approval is based on positive results from the pivotal Phase III ARANOTE trial and bro ...
Federal judge cancels Boeing trial over 737 crashes after agreement with DOJ
Fox Business· 2025-06-03 17:46
Core Points - A federal judge has vacated the trial date for Boeing related to the 737 MAX crashes that resulted in nearly 350 fatalities [1] - The Department of Justice (DOJ) has filed a motion to dismiss the criminal fraud charge against Boeing as part of a non-prosecution agreement [1][4] - Boeing is set to pay $1.1 billion, which includes $445 million allocated to a fund for the families of crash victims [8] Summary by Sections Legal Proceedings - U.S. District Judge Reed O'Connor granted the request from Boeing and the DOJ to vacate the trial date originally scheduled for June 23 in Fort Worth, Texas [1] - The judge must still provide final settlement approval and has the option to reschedule a trial if the deal is not agreed upon [2] Financial Implications - Under the tentative deal, Boeing will pay a total of $1.1 billion, which includes significant compensation for the families affected by the crashes [8] - The DOJ stated that the deal secures meaningful accountability and delivers substantial public benefits [11] Company Commitments - Boeing has expressed its commitment to comply with the obligations under the resolution, which includes additional fines and investments to improve safety systems [8][9] - The company has acknowledged the losses suffered by the families and is committed to honoring their memories through changes in its safety culture [9]